Integrated Clinical Trial Services
Integrated Clinical Trial Services

ICTS Provides Solutions for Rheumatology Study

Raleigh, NC, March 04, 2010 --( Tom Sturgis, president of ICTS (Integrated Clinical Trial Services, LLC) (, has announced that the company has completed the development and implementation of a program designed to increase patient consent in a rheumatology study. The ongoing and parallel studies showed a low consent rate of 7 percent when the trial began. After gathering information about patient communication and using a professional video program to deliver the message, the consent rate in the rheumatology study rose to an average of more than 20 percent.

“We are pleased to deliver measurable results to our clients,” said Sturgis. “Through our effective research and study methods, we were able to considerably raise the consent rate and increase effective patient communication.”

“The true winners here are the patients, who were able to receive the most difficult information in the consent process and fully digest the contents,” said Sturgis. “Communicating important information efficiently has never been more important for clinical trials than it is today.”

- ICTS works to create unique, time sensitive strategies to meet clients’ enrollment challenges.

About ICTS:
ICTS (Integrated Clinical Trial Services, LLC) is a creative, innovative and flexible partner for strategic clinical trials support. The full-service firm utilizes more than 300 contract employees internationally to provide medical communications, patient enrollment feasibility, recruitment strategy, consulting, market research and protocol review, project management, concept design and production, media placement, community resource support, compliance and retention, and more. The ICTS management team has completed more than 300 successful patient recruitment programs and combines for more than 60 years of active involvement in patient accrual. A successful trial depends on the quality of the underlying recruitment plan and ICTS is dedicated to constructing the right solution based upon each client’s protocol and needs. For more information please call (919) 388-3964 or visit the Web site at

Brittney Storm
MMI Public Relations
(919) 233-6600

Integrated Clinical Trial Services
Patty Briguglio